Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Baxter
Boehringer Ingelheim
AstraZeneca

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: SOFOSBUVIR; VELPATASVIR


Email this page to a colleague

« Back to Dashboard

SOFOSBUVIR; VELPATASVIR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir PELLETS;ORAL 214187 NDA Gilead Sciences, Inc. 61958-2204-1 28 PACKET in 1 CARTON (61958-2204-1) > 1 PELLET in 1 PACKET 2021-06-10
Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir PELLETS;ORAL 214187 NDA Gilead Sciences, Inc. 61958-2205-1 28 PACKET in 1 CARTON (61958-2205-1) > 1 PELLET in 1 PACKET 2021-06-10
Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir TABLET;ORAL 208341 NDA Gilead Sciences, Inc. 61958-2201-1 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2201-1) 2016-06-28
Gilead Sciences Inc EPCLUSA sofosbuvir; velpatasvir TABLET;ORAL 208341 NDA Gilead Sciences, Inc. 61958-2203-1 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2203-1) 2020-03-19
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
AstraZeneca
Moodys
Merck
Johnson and Johnson